CCL5 and neoplasm: These results indicate that all treatments [including I (SG511-CCL5-ODD), II (NK-92) and III (SG511-CCL5-ODD92)] inhibited tumor growth and III (SG511-CCL5-ODD92) is the most efficient agent among them.